Open a free Demat account & get ₹500 in stocks.Claim
अ
ArthVani
Nifty 5022,520.450.37%H 22,580.75 · L 22,294.75as of 09 Oct, 3:31 PM IST|Sensex72,472.330.23%H 72,669.2 · L 71,739.49as of 09 Oct, 3:32 PM IST|Bank Nifty55,256.650.37%H 55,419.3 · L 54,617.2as of 09 Oct, 3:31 PM IST|USD / INR₹96.780%H ₹96.78 · L ₹96.5as of 2:02 AM IST|Gold Intl (10g)₹1,31,316.621.52%H ₹1,31,702.45 · L ₹1,29,319as of 2:29 AM IST|Silver Intl (1kg)₹1,90,146.632.84%H ₹1,91,235.67 · L ₹1,84,981.47as of 2:29 AM IST|Crude WTI₹8,870.850.19%H ₹8,919.24 · L ₹8,711.17as of 2:29 AM IST|Bitcoin₹79,90,1970.79%H ₹80,21,607.54 · L ₹79,58,786.46upd. 8:03 AM IST|Ethereum₹2,41,0920.54%H ₹2,41,740.66 · L ₹2,40,443.34upd. 8:03 AM IST|Nifty 5022,520.450.37%H 22,580.75 · L 22,294.75as of 09 Oct, 3:31 PM IST|Sensex72,472.330.23%H 72,669.2 · L 71,739.49as of 09 Oct, 3:32 PM IST|Bank Nifty55,256.650.37%H 55,419.3 · L 54,617.2as of 09 Oct, 3:31 PM IST|USD / INR₹96.780%H ₹96.78 · L ₹96.5as of 2:02 AM IST|Gold Intl (10g)₹1,31,316.621.52%H ₹1,31,702.45 · L ₹1,29,319as of 2:29 AM IST|Silver Intl (1kg)₹1,90,146.632.84%H ₹1,91,235.67 · L ₹1,84,981.47as of 2:29 AM IST|Crude WTI₹8,870.850.19%H ₹8,919.24 · L ₹8,711.17as of 2:29 AM IST|Bitcoin₹79,90,1970.79%H ₹80,21,607.54 · L ₹79,58,786.46upd. 8:03 AM IST|Ethereum₹2,41,0920.54%H ₹2,41,740.66 · L ₹2,40,443.34upd. 8:03 AM IST|
BreakingRBI Cancels Registration of 13 NBFCs, 11 Based in West Bengal1/6
Topicin real-estate

Drug Advertising

Latest news, explainers and analysis on Drug Advertising. Tracking 1 stories on Arth Vani.

1 stories tracked

Connected in the graph

Pharmaceuticals26Regulatory Update133

Latest on Drug Advertising

Health Ministry Proposes New Curbs on Prescription Drug Ads by Retailers
real-estate

Health Ministry Proposes New Curbs on Prescription Drug Ads by Retailers

The Union Health Ministry is moving to restrict how retailers and distributors advertise prescription medicines, requiring prior government approval for certain drugs. This proposed change extends existing rules that currently apply only to pharmaceutical manufacturers and targets medicines under Schedules H, H1, and X, which demand medical supervision.

2h ago·2 min readListen
real-estate products
Compare & act on the right product for this topic
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
14.3%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
11.9%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
10.5%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
10.0%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
10.0%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
8.8%
3Y CAGR
Compare & decide
All comparisons
Read comparison

Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.

Explore all entities in the Knowledge Graph